Start with a free account for 3 free CME credits. Already a subscriber? Sign in.

Mailbag

Matthieu DeClerck, MD and Matthew DeLaney, MD
00:00
14:15
Sign in or subscribe to listen

No me gusta!

The flash player was unable to start. If you have a flash blocker then try unblocking the flash content - it should be visible below.

To view chapter written summaries, you need to subscribe.

Sign up today for full access to all episodes.

Matt M., 6234414 -

This will definitely have me possibly revamp our formulary with a focus on migraine treatment. I am a medical director for 2 clinics - we have zofran, phenergan, benadryl and toradol...we do not have compazine, reglan, narcs, or...of course...droperidol. So my standard approach to the run-of-the-mill migraine patient is ondansetron for N/V, toradol IM, tylenol PO. That is pretty much it. With the info on droperidol, I am definitely going to research that, and very likely try to add it. I guess one question I have is, if we also added compazine, can we pretty much ditch the phenergan since we have zofran. I am thinking yes...need to also research that...but , what is your opinion? Matt Mullen

Mike W., MD -

Compazine is great to use and will also functions as an anti emetic - I have had amazing success w it for the HA cessation also!
M

To join the conversation, you need to subscribe.

Sign up today for full access to all episodes and to join the conversation.

To download files, you need to subscribe.

Sign up today for full access to all episodes.
Urgent Care Rap February 2021 Written Summary 474 KB - PDF

To earn CME for this chapter, you need to subscribe.

Sign up today for full access to all episodes and earn CME.

0.25 Free AMA PRA Category 1 Credits™ certified by Hippo (2021)

  1. Complete Quiz
  2. Complete Evaluation
  3. Print Certificate

3.25 AMA PRA Category 1 Credits™ certified by Hippo (2021)

  1. Complete Quiz
  2. Complete Evaluation
  3. Print Certificate